期刊文献+

颈动脉粥样硬化患者MT2A-838G/C和MCP-1-2518G/A基因多态性分析 被引量:1

Analysis of the MT2A-838G/C and the MCP-1-2518G/A gene polymorphism in carotid arteriosclerosis
下载PDF
导出
摘要 目的:探讨苏南地区汉族人群MT2A-838G/C和MCP-1-2518G/A基因多态性与颈动脉粥样硬化的相关性。方法:采用碱基淬灭探针技术检测103例有颈动脉斑块患者和46例正常对照的MT2A基因-838位点和MCP-1基因-2518位点基因型分布及基因频率,并评价基因多态性与颈动脉粥样硬化易感性之间的相关性。结果:在对照组和病例组中,MT2A 3种基因型GG、GC、CC的频率分别为52.17%、36.96%、10.87%和50.49%、36.89%、12.62%(P>0.05),等位基因G、C的频率分别为70.65%、29.35%和68.93%、31.07%(P>0.05);MCP-1 3种基因型AA、AG、GC在对照组和病例组中的频率分别为15.22%、52.17%、32.61%和20.39%、44.66%、34.95%(P>0.05),等位基因A、G的频率分别为41.30%、58.70%和42.72%、57.28%(P>0.05)。结论:MT2A-838G/C及MCP-1-2518G/A基因多态性可能不是苏南汉族人群发生颈动脉粥样硬化的独立危险因素。 Objective:To assess the potential association of the MT2A-838G/C and the MCP-1-2518G/A gene in patients with carotid arteriosclerosis(CA) in Chinese han population of Jiangsu.Method:A total of 103 consecutive patients with a diagnosis of CA and compared with 46 healthy controls.The polymorphism were detected by base-quenched probe technique,the genotypes and allele frequencies of MT2A-838G/C and MCP-1-2518G/A were calculated.Results:The genotype GG,GC,CC distribution of MT2A were 50.49%,36.89%,12.62% in patients with CA,and were 52.17%,36.96%,10.87% in controls,respectively(P > 0.05).Allele G and C frequency of MT2A in patients with CA were 70.65%,29.35%,and were 68.93%,31.07% in controls,respectively(P > 0.05).The genotype AA,AG,GC distribution of MCP-1 were 20.39%,44.66%,34.95% in patients with CA,and were 15.22%,52.17%,32.61% in controls,respectively(P > 0.05).Allele A and G frequency of MCP-1 in patients with CA were 41.30%,58.70%,and were 42.72%,57.28% in controls,respectively(P > 0.05).Conclusion:The-838G/C of MT2A gene and the-2518G/A of MCP-1 gene may be not the independent risk factor for CA in Chinese Han population of Jiangsu.
出处 《江苏大学学报(医学版)》 CAS 2013年第6期501-504,共4页 Journal of Jiangsu University:Medicine Edition
关键词 颈动脉粥样硬化 金属硫蛋白 单核细胞趋化蛋白-1 单核苷酸多态性 carotid arteriosclerosis metallothioneins single nucleotide polymorphism
  • 相关文献

参考文献13

  • 1Dziegiel P,Jelen M,Muszczynska B. Role of metallothionein expression in non-small cell lung carcinomas[J].{H}Roczniki Akademii Medycznej W Bialymstoku,2004,(Suppl 1):43-45.
  • 2Mendez-Armenta M,Villeda-Hernandez J,Barroso-Moguel R. Brain regional lipid peroxidation and metallothionein levels of developing rats exposed to cadmium and dexamethasone[J].{H}Toxicology Letters,2003,(02):151-157.
  • 3Krzeslak A,Forma E,Jozwiak P. Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer[J].{H}Clinical and Experimental Medicine,2012.
  • 4徐安妨,杨丽霞.Mcp-1及Mcp-1-2518 G/A基因多态性与冠心病的关系[J].西南国防医药,2010,20(11):1265-1266. 被引量:1
  • 5Luo G,Zheng L,Zhang X. Genotyping of single nucleotide polymorphisms using base-quenched probe:a method does not invariably depend on the deoxyguanosine nucleotide[J].{H}Analytical Biochemistry,2009,(02):161-166.
  • 6Steinmetz OM,Panzer U,Harendza S. No association of the-2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy[J].{H}Nephrology Dialysis Transplantation,2004,(03):596-601.
  • 7Gruber HE,Hoelscher G,Ingram JA. 1,25(OH) 2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1,thrombopoietin,VEGF,and angiogenin by human annulus cells in vitro[J].Spine (Phila Pa 1976),2008,(07):755-765.
  • 8Karrer S,Bosserhoff AK,Weiderer P. The-2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis[J].{H}Journal of Investigative Dermatology,2005,(01):92-98.
  • 9Szalai C,Duba J,Prohaszka Z. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD).Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients[J].{H}ATHEROSCLEROSIS,2001,(01):233-239.
  • 10Simeoni E,Winkelmann BR,Hoffmann MM. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis[J].{H}EUROPEAN HEART JOURNAL,2004,(16):1438-1446.

二级参考文献34

  • 1罗光华,郑璐,张晓膺,许国锋,朱江,牟琴峰,魏江,陈陆俊,张俊,徐宁.ShineRoar探针技术检测单核苷酸多态性[J].中华检验医学杂志,2007,30(6):609-612. 被引量:8
  • 2KANG Y J. The antioxidant function of metallothionein in the heart[J]. Proc Soc Exp Biol Med, 1999, 222:263-273.
  • 3GOBEL H, VAN DER WAL A C, TEELING P, et al. Metallothionein in human atherosclerotic lesions: a scavenger mechanism for reactive oxygen species in the plaque? [J].Virehows Arch, 2000, 437:528 -533.
  • 4WU M T, DEMPLE B, BENNETT R A, et al. Indi vidual variability in the zinc inducibility of metallothionein-IIA mRNA in human lymphocytes[J].J Toxicol Environ Health A, 2000, 61:553-567.
  • 5LUOG,ZHENG L,ZHANG X,et al. Genotyping of single nucleotide polymorphismsusing base quenched probe: A method does not invariably depend on the deoxyguanosine nucleotide[J]. Anal Biochem, 2009, 386:161-166.
  • 6GENSINI G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol,1983,51 :606-606.
  • 7MARET W. Zinc coordination environments in proteins as redox sensors and signal transducers[J]. Antioxid RedoxSignal, 2006, 8:1419 -1441.
  • 8BEATTIE J H, KWUN I S. Is zinc deficiency a risk factor for atherosclerosis? [J].Br J Nutr, 2004, 91:177- 181.
  • 9MOCCHEGIANI E, GIACCONI R, CIPRIANO C, et al. MtmRNA gene expression, via IL-6 and glucocortieoids, as potential genetic marker of imrnunosenescence: lessons from very old mice and humans[J].Exp Gerontol, 2002, 37:349-357.
  • 10GIACCONI R, BONFIGLI A R, TESTA R, et al. +647 A/C and + 1245 MTIA polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complieations[J]. Mol Genet Metab, 2008, 94: 98- 104.

共引文献1

同被引文献10

  • 1David-Silva A, Freitas HS, Okamoto MM, et al. Hepa- tocyte nuclear factors 1 o./4c and forkhead box A2 regu- late the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats[ Jl- Life Sci,2013, 93(22) :805 -813.
  • 2Nammo T, Yamagata K, Tanaka T, et al. Expression of HNF4c ( MODY! ), HNF-II3 (MODY5), and HNF- 1 a (MODY3) proteins in the developing mouse pancre- as [ J ]. Gene Expr Patterns, 2008,8 ( 2 ) :96 - 106.
  • 3Chandra V, Huang P, Potluri N, et al. Muhidomain in- tegration in the structure of the HNF-4c nuclear receptor complex[ J ] Nature ,2013,495 (7441) :394 - 398.
  • 4Herman WH, Fajans SS, Smith MJ, et al. Diminished insulin and glueagon secretory responses to arginine in nondiabetic subjects with a nmtation in the hepatocyte nuclear factor-a/MODY1 gene[ J]. Diabetes, 1997,46 ( 11 ) : 1749 - 1754.
  • 5Minra A, Yamagata K, Kakei M, eta]. Hepatocyte nu- clear factor-4c is essential for glucose-stimulated insulin secretion by pancreatic [3-cells[ J]. J Biol Chem,2006, 281 (8) :5246 - 5257.
  • 6Gupta RK, Vatamaniuk MZ, Lee CS, et al. TheMODY1 gene HNF4a regulates selected genes involved in insulin secretion[J]. J Clin Invest,2005,115 (4) : 1006 - 1015.
  • 7Love-Gregory LD, Wasson J, Ma J, et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4c gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish popu- lation[ J]. Diabetes,2004,53 (4) : 1134 - 1140.
  • 8Weedon MN, Owen KR, Shields B, et al. Common va- riants of the hepatocyte nuclear factor4c P2 promoter are associated with type 2 diabetes in the U. K. popula- tion [ J ]. Diabetes, 2004,53 ( 11 ) : 3002 - 3006.
  • 9Hara K, Horikoshi M, Kitazato H, et al. Hepatocyte nuclear factor-4c P2 promoter haplotypes are associated with type 2 diabetes in the Japanese population [ J] Dia- betes, 2006,55 (5) : 1260 - 1264.
  • 10俞力,施良,戴莉敏,孙湘,范钰.内脂素基因启动子多态性与中国人2型糖尿病脂代谢紊乱的相关性[J].中国老年学杂志,2010,30(22):3250-3252. 被引量:6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部